|
1
|
Neville A, Peleg R, Singer Y, Sherf M and
Shvartzman P: Chronic pain: a population-based study. Isr Med Assoc
J. 10:676–680. 2008.PubMed/NCBI
|
|
2
|
Finnerup NB, Sindrup SH and Jensen TS: The
evidence for pharmacological treatment of neuropathic pain. Pain.
150:573–581. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sorge RE, Trang T, Dorfman R, Smith SB,
Beggs S, Ritchie J, Austin JS, Zaykin DV, Vander Meulen H, Costigan
M, et al: Genetically determined P2X7 receptor pore formation
regulates variability in chronic pain sensitivity. Nat Med.
18:595–599. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Myers RR, Campana WM and Shubayev VI: The
role of neuroinflammation in neuropathic pain: mechanisms and
therapeutic targets. Drug Discov Today. 11:8–20. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Moalem G and Tracey DJ: Immune and
inflammatory mechanisms in neuropathic pain. Brain Res Brain Res
Rev. 51:240–264. 2006. View Article : Google Scholar
|
|
6
|
Dominguez E, Rivat C, Pommier B, Mauborgne
A and Pohl M: JAK/STAT3 pathway is activated in spinal cord
microglia after peripheral nerve injury and contributes to
neuropathic pain development in rat. J Neurochem. 107:50–60. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Peppin JF and Webster L: Letter to the
editor in response to 'The evidence for pharmacological treatment
of neuropathic pain̓ by Finnerup et al. Pain. 152:14402011.
View Article : Google Scholar
|
|
8
|
Dominguez E, Mauborgne A, Mallet J,
Desclaux M and Pohl M: SOCS3-mediated blockade of JAK/STAT3
signaling pathway reveals its major contribution to spinal cord
neuroinflammation and mechanical allodynia after peripheral nerve
injury. J Neurosci. 30:5754–5766. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yoshimura A, Naka T and Kubo M: SOCS
proteins, cytokine signalling and immune regulation. Nat Rev
Immunol. 7:454–465. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Funaoka Y, Sakamoto N, Suda G, Itsui Y,
Nakagawa M, Kakinuma S, Watanabe T, Mishima K, Ueyama M, Onozuka I,
et al: Analysis of interferon signaling by infectious hepatitis C
virus clones with substitutions of core amino acids 70 and 91. J
Virol. 85:5986–5994. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Recio C, Oguiza A, Mallavia B, Lazaro I,
Ortiz-Muñoz G, Lopez-Franco O, Egido J and Gomez-Guerrero C: Gene
delivery of suppressors of cytokine signaling (SOCS) inhibits
inflammation and atherosclerosis development in mice. Basic Res
Cardiol. 110:82015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nicholson SE, De Souza D, Fabri LJ, Corbin
J, Willson TA, Zhang JG, Silva A, Asimakis M, Farley A, Nash AD, et
al: Suppressor of cytokine signaling-3 preferentially binds to the
SHP-2-binding site on the shared cytokine receptor subunit gp130.
Proc Natl Acad Sci USA. 97:6493–6498. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shouda T, Yoshida T, Hanada T, Wakioka T,
Oishi M, Miyoshi K, Komiya S, Kosai K, Hanakawa Y, Hashimoto K, et
al: Induction of the cytokine signal regulator SOCS3/CIS3 as a
therapeutic strategy for treating inflammatory arthritis. J Clin
Invest. 108:1781–1788. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jo D, Liu D, Yao S, Collins RD and Hawiger
J: Intracellular protein therapy with SOCS3 inhibits inflammation
and apoptosis. Nat Med. 11:892–898. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Winter J, Jung S, Keller S, Gregory RI and
Diederichs S: Many roads to maturity: microRNA biogenesis pathways
and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Carrington JC and Ambros V: Role of
microRNAs in plant and animal development. Science. 301:336–338.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sakai A and Suzuki H: Emerging roles of
microRNAs in chronic pain. Neurochem Int. 77:58–67. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gong Q, Lu Z, Huang Q, Ruan L, Chen J,
Liang Y, Wang H, Yue Y and Feng S: Altered microRNAs expression
profiling in mice with diabetic neuropathic pain. Biochem Biophys
Res Commun. 456:615–620. 2015. View Article : Google Scholar
|
|
22
|
von Schack D, Agostino MJ, Murray BS, Li
Y, Reddy PS, Chen J, Choe SE, Strassle BW, Li C and Bates B:
Dynamic changes in the microRNA expression profile reveal multiple
regulatory mechanisms in the spinal nerve ligation model of
neuropathic pain. PLoS One. 6:e176702011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bennett GJ and Xie YK: A peripheral
mononeuropathy in rat that produces disorders of pain sensation
like those seen in man. Pain. 33:87–107. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Witting A and Möller T: Microglia cell
culture: a primer for the novice. Methods Mol Biol. 758:49–66.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chaplan SR, Bach FW, Pogrel JW, Chung JM
and Yaksh TL: Quantitative assessment of tactile allodynia in the
rat paw. J Neurosci Methods. 53:55–63. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hargreaves K, Dubner R, Brown F, Flores C
and Joris J: A new and sensitive method for measuring thermal
nociception in cutaneous hyperalgesia. Pain. 32:77–88. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang H, Cang CL, Kawasaki Y, Liang LL,
Zhang YQ, Ji RR and Zhao ZQ: Neurokinin-1 receptor enhances TRPV1
activity in primary sensory neurons via PKCepsilon: a novel pathway
for heat hyperalgesia. J Neurosci. 27:12067–12077. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gilron I, Baron R and Jensen T:
Neuropathic pain: principles of diagnosis and treatment. Mayo Clin
Proc. 90:532–545. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tsuda M, Kohro Y, Yano T, Tsujikawa T,
Kitano J, Tozaki-Saitoh H, Koyanagi S, Ohdo S, Ji RR, Salter MW, et
al: JAK-STAT3 pathway regulates spinal astrocyte proliferation and
neuropathic pain maintenance in rats. Brain. 134:1127–1139. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xue ZJ, Shen L, Wang ZY, Hui SY, Huang YG
and Ma C: STAT3 inhibitor WP1066 as a novel therapeutic agent for
bCCI neuropathic pain rats. Brain Res. 1583:79–88. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang ZF, Li Q, Liu SB, Mi WL, Hu S, Zhao
J, Tian Y, Mao-Ying QL, Jiang JW, Ma HJ, et al: Aspirin-triggered
Lipoxin A4 attenuates mechanical allodynia in association with
inhibiting spinal JAK2/STAT3 signaling in neuropathic pain in rats.
Neuroscience. 273:65–78. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Al-Jamal HA, Jusoh SA, Yong AC, Asan JM,
Hassan R and Johan MF: Silencing of suppressor of cytokine
signaling-3 due to methylation results in phosphorylation of STAT3
in imatinib resistant BCR-ABL positive chronic myeloid leukemia
cells. Asian Pac J Cancer Prev. 15:4555–4561. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wei X, Wang G, Li W, Hu X, Huang Q, Xu K,
Lou W, Wu J, Liang C, Lou Q, et al: Activation of the JAK-STAT3
pathway is associated with the growth of colorectal carcinoma
cells. Oncol Rep. 31:335–341. 2014.
|
|
34
|
Ru P, Steele R, Hsueh EC and Ray RB:
Anti-miR-203 upregulates SOCS3 expression in breast cancer cells
and enhances cisplatin chemosensitivity. Genes Cancer. 2:720–727.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Collins AS, McCoy CE, Lloyd AT, O'Farrelly
C and Stevenson NJ: miR-19a: An effective regulator of SOCS3 and
enhancer of JAK-STAT signalling. PLoS One. 8:e690902013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Patel K, Kollory A, Takashima A, Sarkar S,
Faller DV and Ghosh SK: MicroRNA let-7 downregulates STAT3
phosphorylation in pancreatic cancer cells by increasing SOCS3
expression. Cancer Lett. 347:54–64. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xu G, Yang F, Ding CL, Wang J, Zhao P,
Wang W and Ren H: MiR-221 accentuates IFN's anti-HCV effect by
downregulating SOCS1 and SOCS3. Virology. 462–463:343–350. 2014.
View Article : Google Scholar
|
|
38
|
Bao L, Fu X, Si M, Wang Y, Ma R, Ren X and
Lv H: MicroRNA-185 targets SOCS3 to inhibit beta-cell dysfunction
in diabetes. PLoS One. 10:e01160672015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Im YB, Jee MK, Jung JS, Choi JI, Jang JH
and Kang SK: miR23b ameliorates neuropathic pain in spinal cord by
silencing NADPH oxidase 4. Antioxid Redox Signal. 16:1046–1060.
2012. View Article : Google Scholar
|
|
40
|
Shi G, Shi J, Liu K, Liu N, Wang Y, Fu Z,
Ding J, Jia L and Yuan W: Increased miR-195 aggravates neuropathic
pain by inhibiting autophagy following peripheral nerve injury.
Glia. 61:504–512. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sakai A and Suzuki H: Nerve injury-induced
upregulation of miR-21 in the primary sensory neurons contributes
to neuropathic pain in rats. Biochem Biophys Res Commun.
435:176–181. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sakai A, Saitow F, Miyake N, Miyake K,
Shimada T and Suzuki H: miR-7a alleviates the maintenance of
neuropathic pain through regulation of neuronal excitability.
Brain. 136:2738–2750. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen HP, Zhou W, Kang LM, Yan H, Zhang L,
Xu BH and Cai WH: Intrathecal miR-96 inhibits Nav1.3 expression and
alleviates neuropathic pain in rat following chronic construction
injury. Neurochem Res. 39:76–83. 2014. View Article : Google Scholar
|
|
44
|
Lin CR, Chen KH, Yang CH, Huang HW and
Sheen-Chen SM: Intrathecal miR-183 delivery suppresses mechanical
allodynia in mononeuropathic rats. Eur J Neurosci. 39:1682–1689.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Tan Y, Yang J, Xiang K, Tan Q and Guo Q:
Suppression of microRNA-155 attenuates neuropathic pain by
regulating SOCS1 signalling pathway. Neurochem Res. 40:550–560.
2015. View Article : Google Scholar
|
|
46
|
Guo W, Wang H, Watanabe M, Shimizu K, Zou
S, LaGraize SC, Wei F, Dubner R and Ren K: Glial-cytokine-neuronal
interactions underlying the mechanisms of persistent pain. J
Neurosci. 27:6006–6018. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cao H and Zhang YQ: Spinal glial
activation contributes to pathological pain states. Neurosci
Biobehav Rev. 32:972–983. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kawasaki Y, Zhang L, Cheng JK and Ji RR:
Cytokine mechanisms of central sensitization: distinct and
overlapping role of interleukin-1beta, interleukin-6, and tumor
necrosis factor-alpha in regulating synaptic and neuronal activity
in the superficial spinal cord. J Neurosci. 28:5189–5194. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ji RR, Xu ZZ, Wang X and Lo EH: Matrix
metalloprotease regulation of neuropathic pain. Trends Pharmacol
Sci. 30:336–340. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Jia H, Feng X, Li W, Hu Y, Zeng Q, Liu J
and Xu J: Recombinant human erythropoietin attenuates spinal
neuroimmune activation of neuropathic pain in rats. Ann Clin Lab
Sci. 39:84–91. 2009.PubMed/NCBI
|
|
51
|
Lu Y, Zhao LX, Cao DL and Gao YJ: Spinal
injection of docosahexaenoic acid attenuates carrageenan-induced
inflammatory pain through inhibition of microglia-mediated
neuroinflammation in the spinal cord. Neuroscience. 241:22–31.
2013. View Article : Google Scholar : PubMed/NCBI
|
